These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 33593249)

  • 1. Antimicrobial Activity of 5-membered Nitroheteroaromatic Compounds beyond Nitrofurans and Nitroimidazoles: Recent Progress.
    Kalinin S; Vedekhina T; Paramonova P; Krasavin M
    Curr Med Chem; 2021; 28(29):5926-5982. PubMed ID: 33593249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of in vitro activity of the nitroimidazoles delamanid and pretomanid against multidrug-resistant and extensively drug-resistant tuberculosis.
    Wen S; Jing W; Zhang T; Zong Z; Xue Y; Shang Y; Wang F; Huang H; Chu N; Pang Y
    Eur J Clin Microbiol Infect Dis; 2019 Jul; 38(7):1293-1296. PubMed ID: 30953211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Click Chemistry-Facilitated Structural Diversification of Nitrothiazoles, Nitrofurans, and Nitropyrroles Enhances Antimicrobial Activity against Giardia lamblia.
    Kim WJ; Korthals KA; Li S; Le C; Kalisiak J; Sharpless KB; Fokin VV; Miyamoto Y; Eckmann L
    Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28396548
    [No Abstract]   [Full Text] [Related]  

  • 4. Resistance to the nitroheterocyclic drugs.
    Townson SM; Boreham PF; Upcroft P; Upcroft JA
    Acta Trop; 1994 Mar; 56(2-3):173-94. PubMed ID: 8203303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutagenicity of nitrofurans, nitrothiophenes, nitropyrroles, nitroimidazole, aminothiophenes, and aminothiazoles in Salmonella typhimurium.
    Wang CY; Muraoka K; Bryan GT
    Cancer Res; 1975 Dec; 35(12):3611-7. PubMed ID: 1104157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DprE2 is a molecular target of the anti-tubercular nitroimidazole compounds pretomanid and delamanid.
    Abrahams KA; Batt SM; Gurcha SS; Veerapen N; Bashiri G; Besra GS
    Nat Commun; 2023 Jun; 14(1):3828. PubMed ID: 37380634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delamanid for the treatment of pulmonary multidrug-resistant tuberculosis.
    Thakare R; Soni I; Dasgupta A; Chopra S
    Drugs Today (Barc); 2015 Feb; 51(2):117-23. PubMed ID: 25756067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic Activity of Nitroimidazole-Oxazolidinone Conjugates against Anaerobic Bacteria.
    Zhuang Z; Wan D; Ding J; He S; Zhang Q; Wang X; Yuan Y; Lu Y; Ding CZ; Lynch AS; Upton AM; Cooper CB; Denny WA; Ma Z
    Molecules; 2020 May; 25(10):. PubMed ID: 32456032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study of Structurally Diverse Currently Used and Recently Developed Antimycobacterial Drugs.
    Almehmadi MM; Abdulaziz O; Halawi M; Asif M
    Med Chem; 2023; 19(7):619-652. PubMed ID: 36631919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting nitroimidazole antibiotic resistance mutations in Mycobacterium tuberculosis with protein engineering.
    Lee BM; Harold LK; Almeida DV; Afriat-Jurnou L; Aung HL; Forde BM; Hards K; Pidot SJ; Ahmed FH; Mohamed AE; Taylor MC; West NP; Stinear TP; Greening C; Beatson SA; Nuermberger EL; Cook GM; Jackson CJ
    PLoS Pathog; 2020 Feb; 16(2):e1008287. PubMed ID: 32032366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of a range of novel nitro-aromatic radiosensitizers and bioreductive drugs.
    Fielden EM; Adams GE; Cole S; Naylor MA; O'Neill P; Stephens MA; Stratford IJ
    Int J Radiat Oncol Biol Phys; 1992; 22(4):707-11. PubMed ID: 1544842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations in
    Rifat D; Li SY; Ioerger T; Shah K; Lanoix JP; Lee J; Bashiri G; Sacchettini J; Nuermberger E
    Antimicrob Agents Chemother; 2020 Dec; 65(1):. PubMed ID: 33077652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Action of nitroheterocyclic drugs against Clostridium difficile.
    Kumar M; Adhikari S; Hurdle JG
    Int J Antimicrob Agents; 2014 Oct; 44(4):314-9. PubMed ID: 25129314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacophore modeling of pretomanid (PA-824) derivatives for antitubercular potency against replicating and non-replicating
    Aher RB; Sarkar D
    J Biomol Struct Dyn; 2021 Feb; 39(3):889-900. PubMed ID: 31983295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent Progress in the Discovery and Development of 2-Nitroimidazooxazines and 6-Nitroimidazooxazoles to Treat Tuberculosis and Neglected Tropical Diseases.
    Showalter HD
    Molecules; 2020 Sep; 25(18):. PubMed ID: 32927749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delamanid: From discovery to its use for pulmonary multidrug-resistant tuberculosis (MDR-TB).
    Liu Y; Matsumoto M; Ishida H; Ohguro K; Yoshitake M; Gupta R; Geiter L; Hafkin J
    Tuberculosis (Edinb); 2018 Jul; 111():20-30. PubMed ID: 30029909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bedaquiline and delamanid for drug-resistant tuberculosis: a clinician's perspective.
    Guglielmetti L; Chiesi S; Eimer J; Dominguez J; Masini T; Varaine F; Veziris N; Ader F; Robert J
    Future Microbiol; 2020 Jun; 15():779-799. PubMed ID: 32700565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delamanid when other anti-tuberculosis-treatment regimens failed due to resistance or tolerability.
    Kwon YS; Jeong BH; Koh WJ
    Expert Opin Pharmacother; 2015 Feb; 16(2):253-61. PubMed ID: 25327169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery and characterization of antimycobacterial nitro-containing compounds with distinct mechanisms of action and
    Eke IE; Williams JT; Haiderer ER; Albrecht VJ; Murdoch HM; Abdalla BJ; Abramovitch RB
    Antimicrob Agents Chemother; 2023 Sep; 67(9):e0047423. PubMed ID: 37610224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current development of 5-nitrofuran-2-yl derivatives as antitubercular agents.
    Elsaman T; Mohamed MS; Mohamed MA
    Bioorg Chem; 2019 Jul; 88():102969. PubMed ID: 31077910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.